Transcat (NASDAQ:TRNS) Reaches New 12-Month High at $140.00

Transcat, Inc. (NASDAQ:TRNSGet Free Report) reached a new 52-week high on Tuesday . The company traded as high as $140.00 and last traded at $140.00, with a volume of 14457 shares trading hands. The stock had previously closed at $124.12.

Wall Street Analyst Weigh In

A number of equities research analysts have weighed in on TRNS shares. HC Wainwright raised their price target on Transcat from $124.00 to $156.00 and gave the company a “buy” rating in a research report on Wednesday. TheStreet upgraded Transcat from a “c+” rating to a “b” rating in a research report on Wednesday, January 31st. Oppenheimer raised their price target on Transcat from $125.00 to $160.00 and gave the company an “outperform” rating in a research report on Wednesday. Northland Capmk downgraded Transcat from a “strong-buy” rating to a “hold” rating in a report on Wednesday. Finally, Northland Securities downgraded Transcat from an “outperform” rating to a “market perform” rating in a report on Wednesday. Three analysts have rated the stock with a hold rating and two have assigned a buy rating to the company. According to MarketBeat, the company currently has an average rating of “Hold” and a consensus price target of $134.50.

Get Our Latest Stock Analysis on Transcat

Transcat Stock Performance

The company has a market cap of $1.26 billion, a PE ratio of 89.42 and a beta of 0.61. The company has a current ratio of 3.37, a quick ratio of 2.81 and a debt-to-equity ratio of 0.01. The business has a fifty day moving average of $113.21 and a 200-day moving average of $105.94.

Insider Activity at Transcat

In related news, CEO Lee D. Rudow sold 2,373 shares of the business’s stock in a transaction dated Saturday, March 30th. The stock was sold at an average price of $111.43, for a total transaction of $264,423.39. Following the transaction, the chief executive officer now owns 103,688 shares in the company, valued at approximately $11,553,953.84. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. In other Transcat news, CEO Lee D. Rudow sold 3,343 shares of Transcat stock in a transaction that occurred on Monday, May 20th. The stock was sold at an average price of $124.12, for a total transaction of $414,933.16. Following the sale, the chief executive officer now directly owns 103,692 shares of the company’s stock, valued at approximately $12,870,251.04. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, CEO Lee D. Rudow sold 2,373 shares of Transcat stock in a transaction that occurred on Saturday, March 30th. The shares were sold at an average price of $111.43, for a total value of $264,423.39. Following the sale, the chief executive officer now directly owns 103,688 shares in the company, valued at $11,553,953.84. The disclosure for this sale can be found here. 4.20% of the stock is owned by company insiders.

Institutional Trading of Transcat

Several large investors have recently bought and sold shares of TRNS. Wasatch Advisors LP boosted its position in Transcat by 13.3% during the 4th quarter. Wasatch Advisors LP now owns 701,099 shares of the scientific and technical instruments company’s stock valued at $76,651,000 after acquiring an additional 82,458 shares in the last quarter. Broadcrest Asset Management LLC boosted its position in Transcat by 17.6% during the 4th quarter. Broadcrest Asset Management LLC now owns 400,000 shares of the scientific and technical instruments company’s stock valued at $43,732,000 after acquiring an additional 60,000 shares in the last quarter. Comerica Bank bought a new stake in Transcat during the 3rd quarter valued at approximately $5,221,000. Vanguard Group Inc. boosted its position in shares of Transcat by 13.3% in the 3rd quarter. Vanguard Group Inc. now owns 425,378 shares of the scientific and technical instruments company’s stock worth $41,674,000 after purchasing an additional 49,828 shares in the last quarter. Finally, Charles Schwab Investment Management Inc. boosted its position in shares of Transcat by 196.7% in the 3rd quarter. Charles Schwab Investment Management Inc. now owns 59,482 shares of the scientific and technical instruments company’s stock worth $5,827,000 after purchasing an additional 39,432 shares in the last quarter. 98.34% of the stock is owned by institutional investors.

Transcat Company Profile

(Get Free Report)

Transcat, Inc provides calibration and laboratory instrument services in the United States, Canada, and internationally. It operates through two segments: Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services.

Read More

Receive News & Ratings for Transcat Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Transcat and related companies with MarketBeat.com's FREE daily email newsletter.